Back
Pharming Group NV 10K Form
Buy
51
PHAR
Pharming Group NV
Last Price:
$17.40
Seasonality Move:
6.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PHAR News And Ratings
See the #1 stock for the next 7 days that we like better than PHAR
PHAR Financial Statistics
Sales & Book Value
| Annual Sales: | $296.7M |
|---|---|
| Cash Flow: | $29.9M |
| Price / Cash Flow: | 22.03 |
| Annual Sales: | $3.86 |
| Price / Book: | 4.09 |
Profitability
| EPS (TTM): | 0.01430 |
|---|---|
| Net Income (TTM): | $899.2K |
| Gross Margin: | $250.3M |
| Return on Equity: | 0.39% |
| Return on Assets: | 0.21% |
Pharming Group NV Earnings Forecast
Key Pharming Group NV Financial Ratios
-
The Gross Profit Margin over the past 28 years for PHAR is 84.37%.
-
The Selling, General & Administrative Expenses for PHAR have been equal to 63.75% of Gross Profit Margin.
-
The Research & Development expenses have been 26.70% of Revenue.
-
The Net Earning history of PHAR is -3.98% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 11 years.
Pharming Group NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PHAR |
| Website: | pharming.com |
Debt
| Debt-to-Equity Ratio: | 0.49 |
|---|---|
| Current Ratio: | 3.16 |
| Quick Ratio: | 2.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 248.98 |
PHAR Technical Analysis vs Fundamental Analysis
Buy
51
Pharming Group NV (PHAR)
is a Buy
Is Pharming Group NV a Buy or a Sell?
-
Pharming Group NV stock is rated a BuyThe current Pharming Group NV [PHAR] share price is $15.81. The Score for PHAR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.